CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorska, A. E.
Right arrow Articles by Serra, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorska, A. E.
Right arrow Articles by Serra, R.

Cell Growth & Differentiation, Vol 9, Issue 3 229-238, Copyright © 1998 by American Association of Cancer Research


ARTICLES

Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice

AE Gorska, H Joseph, R Derynck, HL Moses and R Serra
Department of Cell Biology and The Vanderbilt Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2175, USA.

Transforming growth factor (TGF)-beta1 and TGF-beta3 are normally expressed at high levels in the mammary gland during quiescence and at all stages of development, except lactation. Exogenously added TGF-beta1, -beta2, and -beta3 have been shown to regulate growth and differentiation of mammary epithelial cells in vitro and in vivo. TGF-betas signal through a heteromeric complex of type I and type II serine/threonine kinases. The type II receptor is necessary for ligand binding and growth suppression by TGF-betas. Deletions of the cytoplasmic domains of several kinase receptors known to function in multimeric complexes have been shown to act as dominant-negative mutations. To evaluate the role of endogenous TGF-betas in the growth and differentiation of the mammary gland in vivo, we have targeted expression of a truncated, kinase-defective TGF-beta type II receptor to mammary epithelial cells in transgenic mice using the mouse mammary tumor virus promoter/enhancer. Transgene expression was localized to the epithelial cells of terminal ducts and alveolar buds. At approximately 20 weeks of age, virgin female transgenic mice demonstrated varying degrees of mammary epithelial hyperplasia. Mammary glands from transgenic, virgin animals exhibited alveolar development and expression of the milk protein, beta-casein. The data suggest that impaired responsiveness in the epithelium to endogenous TGF-betas results in inappropriate alveolar development and differentiation in the mammary gland. We conclude that endogenous TGF-betas signal to the epithelium to maintain quiescence in the mammary glands of virgin animals.


This article has been cited by other articles:


Home page
Cancer Res.Home page
L. Han, A. Diehl, N. K. Nguyen, P. Korangath, W. Teo, S. Cho, S. Kominsky, D. L. Huso, L. Feigenbaum, A. Rein, et al.
The Notch Pathway Inhibits TGF{beta} Signaling in Breast Cancer through HEYL-Mediated Crosstalk
Cancer Res., November 15, 2014; 74(22): 6509 - 6518.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. S. Jahchan, Y. H. You, W. J. Muller, and K. Luo
Transforming Growth Factor-{beta} Regulator SnoN Modulates Mammary Gland Branching Morphogenesis, Postlactational Involution, and Mammary Tumorigenesis
Cancer Res., May 15, 2010; 70(10): 4204 - 4213.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. M. Francis, J. Bergsied, C. E. Isaac, C. H. Coschi, A. L. Martens, C. V. Hojilla, S. Chakrabarti, G. E. DiMattia, R. Khoka, J. Y. J. Wang, et al.
A Functional Connection between pRB and Transforming Growth Factor {beta} in Growth Inhibition and Mammary Gland Development
Mol. Cell. Biol., August 15, 2009; 29(16): 4455 - 4466.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
W. V. Ingman and S. A. Robertson
Mammary Gland Development in Transforming Growth Factor Beta1 Null Mutant Mice: Systemic and Epithelial Effects
Biol Reprod, October 1, 2008; 79(4): 711 - 717.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Labbe, L. Lock, A. Letamendia, A. E. Gorska, R. Gryfe, S. Gallinger, H. L. Moses, and L. Attisano
Transcriptional Cooperation between the Transforming Growth Factor-{beta} and Wnt Pathways in Mammary and Intestinal Tumorigenesis
Cancer Res., January 1, 2007; 67(1): 75 - 84.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Ge, V. Rajeev, P. Ray, E. Lattime, S. Rittling, S. Medicherla, A. Protter, A. Murphy, J. Chakravarty, S. Dugar, et al.
Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-{beta} Type I Receptor Kinase In vivo.
Clin. Cancer Res., July 15, 2006; 12(14): 4315 - 4330.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
R Serra and M R Crowley
Mouse models of transforming growth factor {beta} impact in breast development and cancer
Endocr. Relat. Cancer, December 1, 2005; 12(4): 749 - 760.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. N. Salm, P. E. Burger, S. Coetzee, K. Goto, D. Moscatelli, and E. L. Wilson
TGF-{beta} maintains dormancy of prostatic stem cells in the proximal region of ducts
J. Cell Biol., July 4, 2005; 170(1): 81 - 90.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Zhang, J. Lee, S. Lu, C. A. Pettaway, and Z. Dong
Blockade of Transforming Growth Factor-{beta} Signaling Suppresses Progression of Androgen-Independent Human Prostate Cancer in Nude Mice
Clin. Cancer Res., June 15, 2005; 11(12): 4512 - 4520.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Forrester, A. Chytil, B. Bierie, M. Aakre, A. E. Gorska, A.-R. Sharif-Afshar, W. J. Muller, and H. L. Moses
Effect of Conditional Knockout of the Type II TGF-{beta} Receptor Gene in Mammary Epithelia on Mammary Gland Development and Polyomavirus Middle T Antigen Induced Tumor Formation and Metastasis
Cancer Res., March 15, 2005; 65(6): 2296 - 2302.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. S. Muraoka-Cook, N. Dumont, and C. L. Arteaga
Dual Role of Transforming Growth Factor ss in Mammary Tumorigenesis and Metastatic Progression
Clin. Cancer Res., January 15, 2005; 11(2): 937s - 943s.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. S. Muraoka-Cook, H. Kurokawa, Y. Koh, J. T. Forbes, L. R. Roebuck, M. H. Barcellos-Hoff, S. E. Moody, L. A. Chodosh, and C. L. Arteaga
Conditional Overexpression of Active Transforming Growth Factor {beta}1 In vivo Accelerates Metastases of Transgenic Mammary Tumors
Cancer Res., December 15, 2004; 64(24): 9002 - 9011.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
C. Han, A. J. Demetris, Y. Liu, J. H. Shelhamer, and T. Wu
Transforming Growth Factor-{beta} (TGF-{beta}) Activates Cytosolic Phospholipase A2{alpha} (cPLA2{alpha})-mediated Prostaglandin E2 (PGE)2/EP1 and Peroxisome Proliferator-activated Receptor-{gamma} (PPAR-{gamma})/Smad Signaling Pathways in Human Liver Cancer Cells: A NOVEL MECHANISM FOR SUBVERSION OF TGF-{beta}-INDUCED MITOINHIBITION
J. Biol. Chem., October 22, 2004; 279(43): 44344 - 44354.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
Y. Ueda, S. Wang, N. Dumont, J. Y. Yi, Y. Koh, and C. L. Arteaga
Overexpression of HER2 (erbB2) in Human Breast Epithelial Cells Unmasks Transforming Growth Factor {beta}-induced Cell Motility
J. Biol. Chem., June 4, 2004; 279(23): 24505 - 24513.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
W. Li, W. Qiao, L. Chen, X. Xu, X. Yang, D. Li, C. Li, S. G. Brodie, M. M. Meguid, L. Hennighausen, et al.
Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice
Development, December 15, 2003; 130(24): 6143 - 6153.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. S. Muraoka, Y. Koh, L. R. Roebuck, M. E. Sanders, D. Brantley-Sieders, A. E. Gorska, H. L. Moses, and C. L. Arteaga
Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor {beta}1
Mol. Cell. Biol., December 1, 2003; 23(23): 8691 - 8703.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. M. Siegel, W. Shu, R. D. Cardiff, W. J. Muller, and J. Massague
Transforming growth factor {beta} signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis
PNAS, July 8, 2003; 100(14): 8430 - 8435.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. S. Jeruss, C. D. Sturgis, A. W. Rademaker, and T. K. Woodruff
Down-Regulation of Activin, Activin Receptors, and Smads in High-Grade Breast Cancer
Cancer Res., July 1, 2003; 63(13): 3783 - 3790.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
C. P. Denton, B. Zheng, L. A. Evans, X. Shi-wen, V. H. Ong, I. Fisher, K. Lazaridis, D. J. Abraham, C. M. Black, and B. de Crombrugghe
Fibroblast-specific Expression of a Kinase-deficient Type II Transforming Growth Factor {beta} (TGF{beta}) Receptor Leads to Paradoxical Activation of TGF{beta} Signaling Pathways with Fibrosis in Transgenic Mice
J. Biol. Chem., June 27, 2003; 278(27): 25109 - 25119.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Guo, P. A. Mathieu, B. Linebaugh, B. F. Sloane, and J. J. Reiners Jr.
Phorbol Ester Activation of a Proteolytic Cascade Capable of Activating Latent Transforming Growth Factor-{beta}: A PROCESS INITIATED BY THE EXOCYTOSIS OF CATHEPSIN B
J. Biol. Chem., April 26, 2002; 277(17): 14829 - 14837.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
Y.-a. Yang, B. Tang, G. Robinson, L. Hennighausen, S. G. Brodie, C.-X. Deng, and L. M. Wakefield
Smad3 in the Mammary Epithelium Has a Nonredundant Role in the Induction of Apoptosis, but not in the Regulation of Proliferation or Differentiation by Transforming Growth Factor-{beta}
Cell Growth Differ., March 1, 2002; 13(3): 123 - 130.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
A. Nguyen and J. Pollard
Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution
Development, January 7, 2000; 127(14): 3107 - 3118.
[Abstract] [PDF]


Home page
Cancer Res.Home page
C. Go, P. Li, and X.-J. Wang
Blocking Transforming Growth Factor {beta} Signaling in Transgenic Epidermis Accelerates Chemical Carcinogenesis: A Mechanism Associated with Increased Angiogenesis
Cancer Res., June 1, 1999; 59(12): 2861 - 2868.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
M. Kretzschmar, J. Doody, I. Timokhina, and J. Massague
A mechanism of repression of TGFbeta / Smad signaling by oncogenic Ras
Genes & Dev., April 1, 1999; 13(7): 804 - 816.
[Abstract] [Full Text]


Home page
JCBHome page
Z. Jiang and E. Zacksenhaus
Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma
J. Cell Biol., January 7, 2002; 156(1): 185 - 198.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1998 by the American Association of Cancer Research.